FindTrial
Sign In

The applicability of rapid serological and molecular testing for Corona SARS-2 in a Dutch population during the COVID-19 outbreak.

The applicability of rapid serological and molecular testing for Corona SARS-2 in a Dutch population during the COVID-19 outbreak. - Research performance point of care diagnostics Corona SARS-2

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49670
Enrollment
300
Registered
2020-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona SARS-2 COVID-19

Interventions

None listed

Sponsors

Ministerie van Defensie
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: zie onder

Exclusion criteria

Exclusion criteria: zie onder

Design outcomes

Primary

MeasureTime frame
nvt—

Secondary

MeasureTime frame
nvt—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)